epistaxis is the clinical term for acute or chronic bleeding from the nasal cavity, most commonly arising from the anterior nasal septum at the Kiesselbach plexus in children and young adults, or from the posterior lateral nasal wall at the Woodruff plexus in older patients. It is distinguished from rhinorrhagia (which implies more severe, uncontrolled nasal hemorrhage) and from hemoptysis (bleeding originating from the lower respiratory tract, though posterior epistaxis may mimic it when blood is expectorated). The underlying mechanism involves mucosal vulnerability from dryness, trauma, inflammation, or systemic coagulopathy leading to vessel rupture; physiologic epistaxis can occur with minor digital trauma in low-humidity environments, while pathologic epistaxis reflects platelet dysfunction, anticoagulant use, or hereditary vascular malformations such as hereditary hemorrhagic telangiectasia (I78.0). Clinically relevant subtypes include anterior epistaxis (self-limited, managed with pressure or cautery; R04.0), posterior epistaxis (often requiring posterior packing or arterial ligation; R04.0), and postoperative epistaxis (a complication of sinonasal or skull-base surgery; T88.8XXA). It is commonly confused with hematemesis (upper GI bleeding with blood vomited through the mouth) — the key difference is that epistaxis blood exits via the nares and may drain posteriorly into the pharynx, whereas hematemesis is preceded by nausea and retching and blood is characteristically coffee-ground or fresh emesis.
The word entered English in the 1790s as epistaxis (noun), borrowed from New Latin epistaxis, from Greek ἐπίσταξις (epístaxis) — literally “a dripping upon,” from epistazein “to drip on, to bleed at the nose.” The earliest recorded medical use dates to 1793. The root stax- (“dripping”) connects epistaxis to the limited -staxis family: staxis (stax- + -is → a dripping of blood or serum from a wound). The epi- prefix is highly productive in medical terminology, appearing in epidermis (epi- + derm- → outer skin layer), epiglottis (epi- + glott- → structure above the vocal cords), epilepsy (epi- + leps- → a seizing upon), epinephrine (epi- + nephr- + -ine → upon the kidney), and epiphysis (epi- + physis → growth plate upon the bone).
🔀 ALIASES / ALTERNATE TERMS
Epistactic / epistaxic(adjective form — include 2-3 clinical collocations where this adjective form appears, e.g., “epistactic bleeding,” “epistaxic episode,” “epistactic focus”)
Nosebleed / nasal hemorrhage(lay and clinical term; note specialty context — e.g., emergency medicine, otolaryngology, family practice)
Minimal epistaxis / blood-streaked mucus(define briefly — e.g., scant or trivial nasal bleeding often dismissed by patients; note relationship to main term as a lesser manifestation)
Rhinorrhagia(clinical synonym used in specific context — e.g., severe or profuse nasal hemorrhage; coded under R04.0)
Anterior epistaxis|Kiesselbach plexus bleed(define this alias briefly and note its ICD-10-CM code — e.g., bleeding from the anterior nasal septum at the Kiesselbach plexus; most common type in children; R04.0)
Posterior epistaxis|Woodruff plexus bleed(systemic or syndromic form — e.g., bleeding from the posterior lateral nasal wall at the Woodruff plexus; often requires packing or embolization; R04.0)
Traumatic epistaxis(define by cause — e.g., due to facial trauma, nasal fracture, or digital manipulation; document with R04.0 plus external cause codes)
Idiopathic (primary) epistaxis(define by cause — e.g., spontaneous bleeding without identifiable local or systemic cause; represents approximately 70% of cases; R04.0)
Iatrogenic / postoperative epistaxis(define by cause — e.g., bleeding as a complication of sinonasal surgery, skull-base surgery, or nasal instrumentation; T88.8XXA)
HHT-associated epistaxis(define by cause — e.g., recurrent epistaxis secondary to hereditary hemorrhagic telangiectasia; often refractory and requiring laser or dermoplasty; I78.0)
Septal epistaxis(organ/tissue-specific form with ICD-10-CM code range — e.g., anterior septal bleeding from Kiesselbach plexus; most common anatomic site; R04.0)
Lateral nasal wall epistaxis(organ/tissue-specific form with ICD-10-CM code range — e.g., posterior bleeding from Woodruff plexus on the lateral wall; R04.0)
Nasopharyngeal drainage(organ/tissue-specific form with ICD-10-CM code range — e.g., posterior bleed with blood draining into the nasopharynx and oropharynx; may present as hemoptysis; R04.0)
Nasal vestibule bleed(organ/tissue-specific form with ICD-10-CM code range — e.g., anterior bleeding localized to the nasal vestibule and columella; R04.0)
🔗 RELATED TERMS
Hemostasis — the opposite process of epistaxis; the physiologic arrest of bleeding through vasoconstriction, platelet plug formation, and coagulation cascade activation; distinguished from epistaxis as termination versus initiation of hemorrhage
Staxis — shares the stax- root; — a general term for dripping of blood or serum from a wound or body surface; epistaxis is the nasal-specific form
Rhinorrhagia — shares the rhin- root; severe or profuse nasal hemorrhage clinically synonymous with epistaxis; R04.0
Hemoptysis — expectoration of blood originating from the respiratory tract below the larynx; posterior epistaxis may be mistaken for hemoptysis when blood drains into the oropharynx and is coughed up; R04.2
Coagulation — the complex physiologic process of blood clotting involving platelet aggregation and the intrinsic/extrinsic clotting cascades; deficiency or disruption results in prolonged epistaxis
Hemostatic — adjective describing nerve, hormonal, or other inputs that sustain, disrupt, or alter tissue; e.g., “trophic support” — describing pharmacologic agents (e.g., thrombin, oxidized cellulose) or physiologic processes that promote clot formation and arrest nasal bleeding
Platelet aggregation — programmed or regulated cellular process underlying physiological and/or pathological forms of this condition — the binding and cross-linking of platelets at the site of subendothelial exposure following nasal mucosal vessel rupture; essential for primary hemostasis
Hereditary hemorrhagic telangiectasia — genetic, acquired, or inflammatory disease whose name includes or is defined by this term; include ICD-10-CM codes in parentheses — e.g., G12.0, G12.1— autosomal dominant vascular dysplasia (ENG, ACVRL1, or SMAD4 mutation) defined by recurrent epistaxis as a cardinal Curaçao diagnostic criterion; I78.0
Juvenile nasopharyngeal angiofibroma — another clinical entity defined by this term; include relevant code range — e.g., H47.2x — benign but locally aggressive vascular tumor of the nasopharynx and pterygopalatine fossa presenting with severe, recurrent epistaxis in adolescent males; D10.6
Thrombocytopenia — another clinical entity defined by this term at a specific anatomic site; e.g., reduction in brain volume, hallmark of neurodegenerative diseases — quantitative platelet deficiency predisposing to spontaneous mucocutaneous bleeding including epistaxis; D69.6
Atrophic rhinitis — another clinical entity; describe association with causative organism or deficiency — e.g., H. pylori, B12 deficiency — chronic nasal mucosal atrophy with crusting, foul odor, and secondary epistaxis due to mucosal fragility; J31.0
Hemophilia A — another clinical entity in a specific specialty — e.g., estrogen-deficiency form in urogynecology — X-linked coagulation factor VIII deficiency characterized by spontaneous mucosal and joint hemorrhage, including difficult-to-control epistaxis; D66
Nasal endoscopy — primary or key diagnostic tool for evaluating this condition or its manifestations — rigid or flexible fiberoptic examination of the nasal cavity and nasopharynx to localize bleeding sources; therapeutic control is reported with 31238, diagnostic evaluation with 31231
CODING CORNER
🏥 ICD-10-CM CODES
Epistaxis | Nasal Hemorrhage (R04.0 — No Laterality/Site Required)
Code
Description
R04.0
Epistaxis (nosebleed; hemorrhage from nose; anterior and posterior unspecified)
Postoperative Epistaxis | Complication of Surgical/Medical Care
Code
Description
T88.8XXA
Other specified complications of surgical and medical care, not elsewhere classified, initial encounter (postoperative nasal hemorrhage)
Hereditary Hemorrhagic Telangiectasia | Genetic/Systemic Form
Emergency department evaluation and management, level 5; for severe hemorrhagic epistaxis with hemodynamic compromise or airway threat
93000
Electrocardiogram, routine ECG with at least 12 leads; for cardiac monitoring during posterior nasal packing (vagal/bradycardia risk)
⚠️ Coding Note: Anterior epistaxis control codes (30901 and 30903) describe unilateral procedures. When bilateral anterior control is performed, append modifier -50 (bilateral procedure) to a single unit of the appropriate code per payer instruction, or bill two units with modifier -50 depending on carrier policy. Posterior epistaxis (30905, 30906) involves a single anatomic area (the nasopharyngeal space); do not apply modifier -50. Correct sequencing requires that R04.0 not be listed as the principal diagnosis when an underlying etiology is documented—sequence I78.0 (HHT), hypertensive disease codes, or trauma codes first, with R04.0 as a secondary manifestation. For postoperative nasal hemorrhage, use T88.8XXA rather than R04.0; documentation must explicitly state “postoperative bleeding” or “complication of surgery.” An undercoding alert applies to posterior epistaxis: when the provider documents “posterior pack placed,” “sphenopalatine artery source,” or “bleeding into posterior pharynx,” query for 30905 instead of 30901. Endoscopic control 31238 bundles the diagnostic endoscopy component; do not separately report 31231 at the same encounter. Modifier -59 (distinct procedural service) may be required if anterior cautery 30901 and endoscopic control 31238 are performed on separate nasal sites with distinct indications.
Crystal's Coder Hub